North carolina

novo nordisk, semaglutide, fda, form 483, north carolina, quality issues, gmp violations

Novo Nordiskā€™s semaglutide facility in North Carolina faces FDA scrutiny over quality issues

Anika Sharma

Novo Nordisk’s shares faced a decline following reports that the FDA had raised concerns about manufacturing issues at the company’s ...

Pfizerā€™s Plant Survives Tornado Damage, Resumes Production

Less than anticipated supply impact from Pfizer’s tornado-damaged factory

SG Tylor

The FDA has addressed the impact of the recent devastating tornado that hit Pfizer’s Rocky Mount facility in North Carolina. ...

Pfizerā€™s North Carolina Plant Hit by Tornado, Threatening US Drug Supply

Pfizer’s North Carolina Facility Hit by Tornado, Raising Concerns About US Medication Supply

SG Tylor

A massive sterile injectables facility, considered one of the world’s largest, has fallen victim to a devastating natural disaster. On ...